Pfizer Inc. pledged donations to support Trump's inauguration and its leadership has been involved in close political engagements with Trump. This marks a sharp turn from earlier condemnation of anti-democratic events, raising concerns about the company aligning with authoritarian political interests.

Pfizer Inc. was among major firms whose top executives attended a high‐level roundtable in Beijing with Chinese President Xi Jinping. At the meeting, Xi called on corporate leaders to help 'uphold global order' amid escalating US-China trade tensions, an engagement raising concerns about alignment with authoritarian political objectives.

Pfizer executives were among the global business leaders who attended a high-level roundtable meeting in Beijing on 2025-03-28, organized by Chinese President Xi Jinping. The meeting, aimed at bolstering foreign investment and reinforcing the global supply chain, raises concerns regarding Pfizer’s willingness to engage with an authoritarian regime in furtherance of its corporate interests.

A Senate investigation has revealed that Pfizer employed a vast tax-dodging strategy by shifting all of its U.S. profits to foreign tax havens through complex, confidential arrangements. The scheme, facilitated by loopholes instated under Republican tax law, allowed Pfizer to avoid paying billions in federal income taxes while reallocating funds to corporate benefits such as stock buybacks and dividends.

Pfizer was represented at a high-profile meeting of top U.S. CEOs, where the discussion focused on distancing from Trump’s authoritarian policy cues. The gathered leaders, including Pfizer, demonstrated a commitment to ethical public behavior by stepping back from ongoing advisory councils and collective support of policies that favor authoritarianism.

Pfizer Inc. provided charter passage funding for pediatric cancer patients evacuated from Gaza as part of a rare cooperation between the Biden and Trump administrations. This action underscores Pfizer's commitment to saving lives in crisis situations, contributing positively to public health and ethical business practices.

Pfizer Inc's reported political contributions and lobbying expenditures for the 2024 cycle indicate significant engagement in political financing and a pronounced revolving door phenomenon. Such activities raise concerns about corporate influence on policymaking and the potential to foster conditions that enable authoritarian practices.

Pfizer released a comprehensive Human Rights Policy Statement detailing its commitment to ethical business practices, including strong labor rights, non-discrimination, and responsible supply chain management in line with international human rights standards.

An analysis of Pfizer's employee-run, nonpartisan political action committee that reviews candidates’ platforms to guide contributions. While the PAC framework appears to democratize political participation among employees, its role in vetting candidates according to corporate interests raises concerns about corporate influence in electoral processes, potentially contributing to an environment supportive of authoritarian policies.

Pfizer published its annual modern slavery statement outlining its comprehensive policies against forced and child labor. The document details its rigorous supplier audits, training initiatives, and internal controls to ensure adherence to ethical labor practices and responsible supply chain management.

The American Democracy Scorecard is tracking Pfizer's political contributions to evaluate whether the company’s funding practices align with pro‐democracy values. The scrutiny raises concerns about transparency and potential influence on political processes.

Pfizer's corporate political contributions policy and trade association reporting reveal the company's active engagement in political processes. Despite legal compliance and transparency measures, this involvement raises concerns about corporate influence over democracy and potential complicity in supporting authoritarian structures by prioritizing corporate interests over public welfare.

A long-term Pfizer employee has sparked a unionization drive at Pfizer’s global manufacturing facility in Portage, citing issues such as wage cuts, outsourcing of labor, and a reduction in overtime pay benefits. The company’s response—asserting that most workers are not interested in unionizing and preferring to address issues directly—raises concerns about its commitment to fair labor practices and ethical business responsibilities.